From the AUA – Treated Positive Surgical Margins Impact Survival

Currently the American Urologic Association is holding their annual conference. Like the ASCO and AACR conferences there are many presentations and posters given that harkens the latest in research findings for general urological topics as well as for prostate cancer. I will be reporting on a number of these findings over the next period of [...]

The Role of Hope and Faith In Fighting Prostate Cancer

You are sitting in your doctor’s office listening to the doctor tell you that you have prostate cancer! Immediately, numbness and disbelief creep into your reality. Over time, the news sinks in and you begin to understand the diagnosis, you have cancer. Your world has been changed and will never be the same. All of [...]

New Approved Drugs Keep Us in the Proverbial Pickle

Over the last year or so we have seen a marked change in the treatment landscape for men with castrate resistant advanced prostate cancer. The FDA has approved sipuleucel-T (Provenge), cabazitaxel (Jevtana) and last week it also approved abiraterone (Zytiga). This changed landscape of multiple treatment options creates new problems, of course good problems. Prostate [...]

IMPORTANT ALERT- RECALL OF COUMADIN (WARFIN SODIUM) 5 mg Tabs

Recall: Coumadin (warfarin sodium) Crystalline 5 mg Tablets - Tablets May Have Higher than Expected Potency ISSUE: Bristol-Myers Squibb initiated a voluntary recall of one lot of 1,000-count bottles of Coumadin (warfarin sodium) Crystalline 5 mg tablets. Company testing of tablets from a returned bottle found a tablet to be higher in potency than expected. [...]

A Confirmatory Study – Acupuncture Provides Relief for Men on ADT

Another small confirmatory study of acupuncture to treat the side effects of hormone deprivation (ADT) was published in the International Journal of Radiation Oncology. The study found that acupuncture appears to provide long-lasting relief to hot flashes, heart palpitations, and anxiety due to side effects of hormone treatment for prostate cancer. […]

Go to Top